Blood and Lymphatic Cancer Targets and Therapy
Last updated ISSN 1179-9889
Blood and Lymphatic Cancer Targets and Therapy is published by Dove Medical Press in medicine. It is open access. The article processing charge is $2,320.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Blood and Lymphatic Cancer Targets and Therapy is — and show you journals like it.
What it publishes
Recent work in Blood and Lymphatic Cancer Targets and Therapy concentrates on these topics, taken from its published record rather than from its own description:
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- CAR-T cell therapy research
- CNS Lymphoma Diagnosis and Treatment
- Protein Degradation and Inhibitors
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Key facts
| Publisher | Dove Medical Press |
|---|---|
| ISSN | 1179-9889 |
| Subject area | Medicine |
| Access | Open access |
| Article processing charge | $2,320 |
| Indexed in | Scopus · DOAJ |
| Articles published | 149 |
| Publishing since | 2011 |
| Journal website | www.dovepress.com/blood-and-lymphatic-cancer-targets |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Blood and Lymphatic Cancer Targets and Therapy
Other established journals in medicine, if this one is not the right home for your paper: